 |
|
Successful Use of a Paracorporeal Left Ventricular Assist Device in Man
Robert L. Berger, MD;
John R. McCormick, MD;
Joseph D. Stetz, MD;
Michael D. Klein, MD;
Thomas J. Ryan, MD;
James Carr;
Stephen Sweet, MD;
William F. Bernhard, MD
JAMA. 1980;243(1):46-49.
Abstract
A paracorporeal left ventricular assist device (LVAD) with a capacity to pump 8 L/min of blood was employed in a clinical trial, and this report details the first survivor. A 60-year-old man could not be separated from the pump oxygenator following coronary artery bypass grafting, and, therefore, an LVAD was employed. Almost the entire left ventricular workload was assumed by the mechanical pump so that the myocardium was allowed to rest and recover. The LVAD support was continued for 105 hours. It provided satisfactory total body perfusion with maintenance of good hemodynamics—without serious deleterious effects on hematologic factors. The patient is alive and active without cardiac symptoms 16 months after his operation. The total experience with 13 LVAD implantations warrants continuation of the clinical trials in selected patients.
(JAMA 243:46-49, 1980)
Author Affiliations
From the Department of Cardiothoracic Surgery, University Hospital and Boston University School of Medicine (Drs Berger, McCormick, Stetz, Klein, Ryan, and Sweet) and Children's Hospital Medical Center and Harvard Medical School (Drs Carr and Bernhard), Boston.
Footnotes
Reprint requests to Department of Cardiothoracic Surgery, University Hospital, 75 E Newton St, Boston, MA 02118 (Dr Berger).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
'Pulsatile' Left Atrial-Femoral Artery Bypass: A New Method of Preventing Extension of Myocardial Infarction
Laschinger et al.
Arch Surg 1983;118:965-969.
ABSTRACT
Intracorporeal (Abdominal) Left Ventricular Assist Devices or Partial Artificial Hearts: A Five-Year Clinical Experience
Norman et al.
Arch Surg 1981;116:1441-1445.
ABSTRACT
|
